Amyotrophic Lateral Sclerosis Modifiers inDrosophilaReveal the Phospholipase D Pathway as a Potential Therapeutic Target
- 1 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Genetics
- Vol. 215 (3) , 747-766
Abstract
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a devastating neurodegenerative disorder lacking effective treatments. ALS pathology is linked to mutations in >20 different genes indicating a complex underlying genetic architecture that is effectively unknown. Here, in an attempt to identify genes and pathways for potential therapeutic intervention and explore the genetic circuitry underlying Drosophila models of ALS, we carry out two independent genome-wide screens for modifiers of degenerative phenotypes associated with the expression of transgenic constructs carrying familial ALS-causing alleles of FUS (hFUSR521C) and TDP-43 (hTDP-43M337V). We uncover a complex array of genes affecting either or both of the two strains, and investigate their activities in additional ALS models. Our studies indicate the pathway that governs phospholipase D activity as a major modifier of ALS-related phenotypes, a notion supported by data we generated in mice and others collected in humans.Keywords
This publication has 135 references indexed in Scilit:
- Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110Cell Death & Disease, 2013
- The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative diseaseBrain Research, 2012
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- A Protein Complex Network of Drosophila melanogasterCell, 2011
- The phospholipase D1 pathway modulates macroautophagyNature Communications, 2010
- A Drosophila model for TDP-43 proteinopathyProceedings of the National Academy of Sciences, 2010
- TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationProceedings of the National Academy of Sciences, 2009
- The splicing-factor oncoprotein SF2/ASF activates mTORC1Proceedings of the National Academy of Sciences, 2008
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004